128 related articles for article (PubMed ID: 10334666)
1. Should anaemia in subtypes of CRF patients be managed differently?
van Ypersele de Strihou C
Nephrol Dial Transplant; 1999; 14 Suppl 2():37-45. PubMed ID: 10334666
[TBL] [Abstract][Full Text] [Related]
2. Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure.
Dunn CJ; Markham A
Drugs; 1996 Feb; 51(2):299-318. PubMed ID: 8808169
[TBL] [Abstract][Full Text] [Related]
3. Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.
Dunn CJ; Wagstaff AJ
Drugs Aging; 1995 Aug; 7(2):131-56. PubMed ID: 7579784
[TBL] [Abstract][Full Text] [Related]
4. [Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].
Jungers PY; Nguyen-Khoa T; Joly D; Choukroun G; Massy ZA; Jungers P
Presse Med; 2003 Feb; 32(5):212-6. PubMed ID: 12610461
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage.
Port RE; Kiepe D; Van Guilder M; Jelliffe RW; Mehls O
Clin Pharmacokinet; 2004; 43(1):57-70. PubMed ID: 14715051
[TBL] [Abstract][Full Text] [Related]
6. What are the short-term and long-term consequences of anaemia in CRF patients?
Mann JF
Nephrol Dial Transplant; 1999; 14 Suppl 2():29-36. PubMed ID: 10334665
[TBL] [Abstract][Full Text] [Related]
7. Management of early renal anaemia: diagnostic work-up, iron therapy, epoetin therapy.
Van Wyck DB
Nephrol Dial Transplant; 2000; 15 Suppl 3():36-9. PubMed ID: 11032356
[TBL] [Abstract][Full Text] [Related]
8. A study of the response of elderly patients with end-stage renal disease to epoetin alfa or beta.
Nicholas JC
Drugs Aging; 2004; 21(3):187-201. PubMed ID: 14979736
[TBL] [Abstract][Full Text] [Related]
9. Is there a role for adjuvant therapy in patients being treated with epoetin?
Hörl WH
Nephrol Dial Transplant; 1999; 14 Suppl 2():50-60. PubMed ID: 10334668
[TBL] [Abstract][Full Text] [Related]
10. Epoetin delta is effective for the management of anaemia associated with chronic kidney disease.
Spinowitz BS; Pratt RD;
Curr Med Res Opin; 2006 Dec; 22(12):2507-13. PubMed ID: 17166333
[TBL] [Abstract][Full Text] [Related]
11. [Guidelines for the treatment of anemia in chronic renal failure].
Triolo G;
G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
13. Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).
Levin NW; Fishbane S; Cañedo FV; Zeig S; Nassar GM; Moran JE; Villa G; Beyer U; Oguey D;
Lancet; 2007 Oct; 370(9596):1415-21. PubMed ID: 17950856
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of intervention in early renal disease.
Portolés J
Nephrol Dial Transplant; 2001; 16 Suppl 2():12-5. PubMed ID: 11369843
[TBL] [Abstract][Full Text] [Related]
15. New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial.
Laville M;
Acta Diabetol; 2004 Mar; 41 Suppl 1():S18-22. PubMed ID: 15103544
[TBL] [Abstract][Full Text] [Related]
16. Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.
Faulds D; Sorkin EM
Drugs; 1989 Dec; 38(6):863-99. PubMed ID: 2693045
[TBL] [Abstract][Full Text] [Related]
17. Epoetin delta as an antifibrotic agent in the remnant kidney rat: a possible role for transforming growth factor beta and hepatocyte growth factor.
De Beuf A; D'Haese PC; Verhulst A
Nephron Exp Nephrol; 2010; 115(3):e46-59. PubMed ID: 20424483
[TBL] [Abstract][Full Text] [Related]
18. A comparison between once-weekly and twice- or thrice-weekly subcutaneous injection of epoetin alfa: results from a randomized controlled multicentre study.
Lee YK; Kim SG; Seo JW; Oh JE; Yoon JW; Koo JR; Kim HJ; Noh JW
Nephrol Dial Transplant; 2008 Oct; 23(10):3240-6. PubMed ID: 18469158
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients.
Rossert J; Gassmann-Mayer C; Frei D; McClellan W
Nephrol Dial Transplant; 2007 Mar; 22(3):794-800. PubMed ID: 17210593
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.
Furuland H; Linde T; Ahlmén J; Christensson A; Strömbom U; Danielson BG
Nephrol Dial Transplant; 2003 Feb; 18(2):353-61. PubMed ID: 12543892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
